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Abstract
Misregulation of gene expression can result in broad types of diseases and abnormalities.
For elucidating the molecular mechanisms underlying evolution, development and disease, the
2% protein-coding regions in the human genome have been studied for decades, but the the 98%
non-coding regions remain less understood. Many studies have revealed that evolutionary con-
served non-coding elements (CNEs) act as cis-regulatory elements (CREs). Nevertheless, not all
CREs are evolutionary conserved and, hence, the identification of CREs has proved challenging.
Some CREs work cooperatively to regulate gene expression. Together with their target gene(s),
these CREs form regulatory units. For instance, topologically associating domains (TADs) are
large regulatory units in the genome, controlling and restricting the interactions between genes
and CREs. Many studies have found the disruption of TADs can lead to gene expression mis-
regulation.
This thesis aimed at characterizing regulatory units. In particular, we explored the mecha-
nisms by which regulatory unit disruption can lead to changes in gene expression in evolution,
development, and disease.
The first part of this thesis focused on the identification and characterization of small reg-
ulatory units consisting of two CREs. We identified 5,500 pairs of adjacent CNEs (to which
we further refer as “CNE-CNE pairs”) in the human genome with either expanded, conserved
or contracted inter-CNE sequences compared to the common mammalian ancestor. Particu-
larly, the CNEs in CNE-CNE pairs with conserved and mildly contracted inter-CNEs sequences
were most likely to perform as active or poised enhancers; in addition, both CNEs of the pairs
exhibited similar epigenetic profiles, suggesting that the CNE-CNE pairs tend to act as small
regulatory units. Furthermore, transposon deletions and insertions were associated with the con-
traction or expansion of inter-CNE sequences, indicating that transposon activity might disrupt
the link between the two CNEs in the CNE-CNE pairs, leading to a loss of cis-regulatory func-
tion. Our study identified novel regulatory units, and highlighted the existence of cooperative
interaction between adjacent CREs in the regulatory units that are distance-sensitive and can be
disrupted by transposon activity. Our findings contribute to understanding the mechanism by
which selective forces act on CREs in the context of evolution and human genetic diseases.
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The second part of this thesis investigated the mechanisms by which regulatory units can
be disrupted, leading to gene expression misregulation in disease. To address this, we first
constructed 1,467 consensus TADs in the “normal genome” and 1,622 consensus TADs in the
“cancer genome”. To evaluate the prognosis value of knowing the location of structural variants
such as copy number variants (CNVs) within the TADs in cancer patient survival outcome, we
applied Cox regression analysis. In this manner, we identified 35 prognostic TADs; 54% of these
TADs did not contain any genes with a known association to cancer causality, indicating that a
large fraction of the TADs have prognostic value independently of coding variants. Furthermore,
34% of the 35 prognostic TADs underwent strong structural perturbations in the cancer genome.
Hence, the prognostic value of at least a fraction of the 35 TADs appeared to be associated with
the disruption of normal CRE interactions. Our study emphasized the importance of identifying
perturbed regulatory units in monitoring cancer development and progression.
Understanding the molecular mechanisms regulating gene expression will help us to under-
stand the formation and evolution of life and to find cures for diseases.
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Zusammenfassung
Eine fehlerhafte Regulation der Genexpression kann zu einem breiten Spektrum an Krankheiten
und Abnormitäten führen. Zur Aufklärung der molekularen Mechanismen, die Evolution, En-
twicklung und Krankheit zugrunde liegen, werden die 2% protein-kodierenden Regionen im
menschlichen Genom seit Jahrzehnten untersucht, die 98% nichtkodierenden Regionen sind
bisher deutlich weniger gut verstanden. Viele Studien haben gezeigt, dass evolutionär kon-
servierte nicht-kodierende Elemente (KNEs) als cis-regulatorische Elemente (CREs) fungieren.
Jedoch sind nicht alle CREs evolutionär konserviert, weswegen sich die Identifizierung von
CREs als schwierig erwiesen hat. Einige CREs regulieren dieGenexpression kooperativ. Zusam-
men mit ihrem Zielgen oder ihren Zielgenen bilden diese CREs Regulationseinheiten. Zum
Beispiel sind topologisch assoziierendeDomänen (TADs) großeRegulationseinheiten imGenom,
die die Interaktionen zwischen Genen und CREs kontrollieren und einschränken. Viele Studien
haben bestätigt, dass die Störung der TAD-Struktur zu einer fehlerhaften Genexpression führen
kann.
Diese Arbeit zielte auf die Charakterisierung von Regulationseinheiten ab. Insbesondere
hat sie die Mechanismen erforscht, durch die eine Störung von Regulationseinheiten zu Verän-
derungen der Genexpression führt, im Kontext von Evolution, Entwicklung und Krankheit.
Der erste Teil dieser Arbeit hat sich mit der Identifizierung und Charakterisierung kleiner
Regulationseinheiten, bestehend aus zwei CREs, befasst. Wir haben 5500 Paare benachbarter
KNEs im menschlichen Genom identifiziert (im Folgenden als ”KNE-KNE-Paare” bezeich-
net), bei denen die Inter-KNE-Sequenzen im Vergleich zu dem gemeinsamen Vorfahren der
Säugetiere entweder expandiert, konserviert, oder kontrahiert sind. Insbesondere die KNEs
in KNE-KNE-Paaren mit konservierten oder leicht kontrahierten Inter-KNE-Sequenzen wiesen
die größte Wahrscheinlichkeit auf, als aktive Enhancer oder ”poised” Enhancer (d.h., in Bere-
itschaftsstellung) zu fungieren. Des Weiteren zeigten die zu einem Paar gehörenden KNEs ähn-
liche epigenetische Profile, was darauf hindeutet, dass die KNE-KNE-Paare als kleine Regu-
lationseinheiten fungieren. Darüber hinaus waren Transposon-Deletionen (respektive Insertio-
nen) mit einer Kontraktion (respektive Expansion) der Inter-KNE-Sequenzen assoziiert. Dies
deutet an, dass die Transposonaktivität möglicherweise den funktionellen Zusammenhang zwis-
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chen den beidenKNEs in denKNE-KNE-Paaren stört und so zu einemVerlust ihrer cis-regulatorischen
Funktion führt. Unsere Studie hat neue Regulationseinheiten identifiziert und die Existenz ko-
operativer Interaktionen zwischen benachbarten CREs, die sich in distanzsensitiven und durch
Transposonaktivität zerstörbarenRegulationseinheiten befinden, hervorgehoben. Unsere Ergeb-
nisse tragen zum Verständnis des Mechanismus bei, durch den selektive Kräfte auf CREs im
Kontext von Evolution und genetisch bedingten Erkrankungen des Menschen wirken.
Der zweite Teil dieser Arbeit hat die Mechanismen untersucht, durch die Regulationsein-
heiten gestört werden können, was zu einer Fehlregulation der Genexpression bei Krankheiten
führt. Hierzu haben wir zunächst 1467 Konsensus-TADs im „normalen Genom“ und 1622
Konsensus-TADs im „Krebsgenom“ konstruiert. Um den prognostischenWert der Kenntnis der
Position von Strukturvarianten wie Kopienzahlvarianten (KZVs) innerhalb der TADs bezüglich
der Überlebensdauer von Krebspatienten zu ermitteln, haben wir eine Cox-Regressionsanalyse
durchgeführt. Auf dieseWeise haben wir 35 prognostische TADs identifiziert; 54% dieser TADs
enthielten keine Gene mit einem bekannten Zusammenhang mit der Krebsursache, was darauf
hinweist, dass ein großer Teil der TADs unabhängig von kodierenden Varianten einen prog-
nostischen Wert hat. Darüber hinaus zeigten 34% der 35 prognostischen TADs starke struk-
turelle Störungen im Krebsgenom. Daher schien der prognostische Wert von mindestens einem
Bruchteil der 35 TADs mit der Störung normaler CRE-Interaktionen verbunden zu sein. Unsere
Studie zeigt, wie wichtig es ist, gestörte Regulationseinheiten zur Überwachung der Krebsen-
twicklung und -progression zu identifizieren.
Das Verständnis der molekularen Mechanismen, die die Genexpression regulieren, wird uns
helfen die Entstehung und Evolution des Lebens zu verstehen und Heilmittel für Krankheiten
zu finden.
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1 . Introduction
1. Introduction
1.1 Gene Expression Regulation in Eukaryotes
Genes are the DNA sequences in the genome that code for proteins. The process by which
a gene gives rise to a protein is called “gene expression” and comprises two major steps: tran-
scription and translation. During transcription, the DNA that forms the gene is transcribed to
messenger RNA (mRNA). Then, the genetic information in the mRNA is used to build a chain of
amino acids in the process of translation. The two processes comprise three stages: initiation,
elongation, and termination. In eukaryotic organisms, gene expression is primarily regulated
at the level of transcription initiation [1]. Gene expression regulation ensures the appropriate
level of expression in the correct cell type at the right time point during cell differentiation and
organismal development, and gene expression misregulation can result in a broad spectrum of
diseases [2]. Understanding the mechanisms of gene expression regulation is crucial for unrav-
eling how different patterns of gene expression control cell differentiation, development, and
even cause diseases.
1.1.1 Transcription factors and cis-regulatory elements
Only 2% of the human genome codes for proteins [3]. The remaining 98% of the genome
is non-coding in nature. A non-negligible fraction of the non-coding genome plays a function
in gene expression regulation and RNA processing [4]. In the past decades, different analysis
techniques have been applied to annotate non-coding sequences. However, the comprehensive
functional profiling of the non-coding genome still requires more time and effort.
In the process of gene transcription, mRNA synthesis is carried out by RNA polymerase
enzymes. In particular, the synthesis of mRNA precursors is catalyzed by the RNA polymerase
II. The process is regulated by multiple transcription factors (TFs) [5]: proteins that work alone
or combine with other proteins in a complex to promote or prevent the recruitment of the RNA
polymerase to a specific gene. TFs are regarded as key components in gene regulatory net-
works and comprise a diverse family of proteins. The DNA sequences encoding TFs or other
1
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DNA-binding proteins are called trans-regulatory elements (TREs). TFs contain specific DNA-
binding domains that recognize and attach to specific DNA sequences, known as cis-regulatory
elements (CREs). The short DNA sequences located within CREs, which physically interact
with the TFs and bind to them, are called TF binding sites (TFBSs) and are typically less than
30 base pairs (bp) in length. TFBSs represent the sequence features of regulatory regions and the
conserved sequence patterns of a collection of similar TFBSs are known as a TFBS motif. The
accurate detection and characterization of TFBSs are essential contributions to understand the
mechanisms of gene expression regulation. Some resources have been developed to annotate
TFBS profiles in several species, such as JASPAR and GTRD [6, 7].
In the genome, CREs are brought into the proximity of their target genes through the for-
mation of chromatin loops and may be located distantly from them [8, 9]. The binding of TFs
to CREs can initiate, enhance or suppress transcription. According to their regulatory func-
tions, CREs are commonly categorized into promoters, enhancers, silencers and insulators. In
particular, promoters and enhancers are the best understood types.
Promoters are about 100-1000 bp long and are required to initiate transcription. Most pro-
moters recognized by the RNA polymerase II are characterized by the presence of a 25 to 35
bp-long TATA box [10]. Promoters are located immediately upstream of the transcription start
site (TSS) of their target genes, which makes it easy to find them. Enhancers vary from about
50 to 1500 bp in length [11]. Enhancers can increase the activity of the promoter of their target
genes and, thereby, their transcription levels, under specific conditions. The location of the en-
hancers relative to their target genes is highly variable: they can lie upstream, downstream or
within introns of the genes that they regulate or be located far away [12]. Silencers are similar
to enhancers, but involved in repression of transcription [13]. Finally, insulators are typically
500 to 3,000 bp-long sequences blocking promoter-enhancer interactions and serving as barriers
against the spreading of the silencing effects of heterochromatin. The nuclear protein CCCTC-
binding factor (CTCF) is an example of an insulator-binding protein. CTCF binds to insulators
in the genome and mediates insulation through preventing the crosstalk between active and in-
active genomic regions [14]. The functional cooperation between multiple regulatory elements
(CREs and TREs) maintains the accurate gene expression.
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1.1.2 Epigenetic regulation of gene expression
In eukaryotes, the DNA is organized into chromatin, a complex in which the DNA is
wrapped around histone proteins. According to its level of compaction, the chromatin can be
classified as euchromatin or heterochromatin. While the euchromatin is a gene-rich, loosely
compact structure associated with active gene transcription, the heterochromatin is a gene-poor,
firmly compact structure transcriptionally silent [15, 16]. The chromatin structure and DNA ac-
cessibility are regulated by covalent modifications of the histones and DNAmethylation. These
are known as epigenetic modifications [17]. By modifying the chromatin structure and DNA
accessibility, epigenetic modifications can regulate gene expression.
The histones form octamers containing two copies of each of four histone proteins, mainly
H2A, H2B, H3 and H4. The N-terminal tail of the histones is subject to a number of post-
translational modifications, referred to as “histone modifications”. Histone modifications com-
prise several types, such asmethylation, phosphorylation, acetylation, ubiquitylation, and sumoy-
lation [18]. Histone modification patterns are thought to constitute a “histone code” that regu-
lates the dynamics of chromatin organization and function. In particular, individual histonemod-
ification can distinguish euchromatin from heterochromatin [19]. Thus, heterochromatin is en-
riched in hypoacetylated histones and methylated lysine 9 of histone H3 (H3K9me), whereas eu-
chromatin is characterized by acetylated histonesH3/H4 andmethylated lysine 4 ofH3 (H3K4me)
[20, 21, 22]. In addition, particular histone modifications are associated with different transcrip-
tional states. For instance, lysine methylation is associated with repressed transcription, whereas
lysine acetylation is related to active transcription [18, 23].
DNA methylation is the biological process involving the transfer of a methyl group onto the
C5 position of the cytosine to form 5-methylcytosine within the context of the CpG dinucleotide
[24]. DNA methylation and histone H3K9 methylation can cooperatively form and maintain
regions of heterochromatin. In particular, DNAmethylation represses transcription by recruiting
methyl-binding proteins and their associated chromatin remodeling factors or by preventing
TFs from binding to the DNA [25]. Normal DNA methylation patterns contribute to maintain
genome stability and accurate gene expression. Global hypomethylation together with region-
specific hypermethylation is frequently observed in tumor cells, resulting in gene expression
3
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misregulation [26].
Epigenetic mechanisms can maintain chromatin stability and regulate gene activity during
organismal development, and their alterations can result in various human diseases [27]. Re-
cent genome-wide technologies have enabled us to perform a systematic exploration of histone
modifications and DNA methylation profiles, advancing the characterization of the epigenetic
landscape of the genome.
1.1.3 Topologically associating domains (TADs)
The genomic DNA has been found to form three-dimensional (3D) structures. Most notably,
the genome is organized into topologically associated domains (TADs), which are megabase-
sized genomic regions harboring self-interacting chromatin loops [28]. The insulator protein
CTCF plays an important role in the formation of TADs. Indeed, CTCF has been found to be en-
riched at chromatin loops [29]; in turn, CTCF sites are enriched in TADboundary regions (TBRs,
[30]). TADs contribute to gene regulation by restricting or facilitating promoter-enhancer inter-
actions in a cell-specific manner [31].
Numerous studies have revealed that TADs can be further characterized into two compart-
ments A and B, enriched with either active and open or inactive and closed chromatin, respec-
tively [32, 33]. Compartments that are active in a specific cell type or condition can be inactive
in other cell type or condition, and vice versa [34]. Although compartment switching was ini-
tially thought to play a major role in the regulation of gene expression during cell differentiation
[35], compartment switching have been recently shown to contribute, but not determine cell type
specific patterns of gene expression [36]. Chromatin compartmentalization is believed to be a
key characteristics of high-order genome organization and function in animal development [37].
But recent evidence showed CTCF loss only displayed small effects on compartments whereas
cohesin loss could obviously increase the degree of compartmentalization, suggesting compart-
ments and TADs might be formed by distinct, probably antagonistic mechanism [38]. Currently,
how exactly the dynamics of chromatin organization affects gene expression regulation remains
unclear.
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1.2 Genomic variants and gene expression misregulation
In the context of diseases and abnormalities, epigenetics, TADs, and dynamics of chromatin
structure are shown to be disrupted by genomic variants, and in turn, cause gene expression
misregulation. There are two major categories of genomic variants: (i) single nucleotide poly-
morphisms (SNPs) and short insertions and deletions (indels); and (ii) structural variants (SVs),
which are rearrangements of large DNA segments and may involve DNA copy number variants
(CNVs). The most common SVs comprise deletions, duplications, inversions and translocations
and are regarded as one of the hallmarks of cancer [39]. Variants can be located everywhere in
the genome and variants in both coding and non-coding sequences have been associated with
phenotypic diversity in health and disease.
SNPs are substitutions of single nucleotides and occur throughout the genome with a fre-
quency of one in approximately every 1,000 bp [40]. SNPs are associated with population di-
versity in health [41], the susceptibility of an individual to many diseases [42], and individual
response to medicinal drug treatment in diseases [43]. For example, the SNP rs3903072, located
within a putative CRE of the tumor suppressor gene CTSW, is associated with low expression
level of CTSW and lower survival probability in breast cancer patients [44]. Also, the SNP
rs2853669 within the promoter of gene encoding the telomerase reverse transcriptase (TERT)
can influence patient survival rates, recurrence risks, and prognosis of human diseases, e.g. liver
cancer, breast cancer, ovarian cancer and melanoma [45, 46, 47].
While not as common as SNPs, indels still make up 15-20% of human polymorphisms,
representing the secondmost common type of genetic variants in the human genome [48]. Indels
comprise insertions or deletionsmeasuring from 1 to 10kb in length. Many studies have revealed
that non-coding indels can affect the regulation of cancer-related genes and are associated with
lower patient survival [49, 50].
Most SVs encompass more than one gene or regulatory element; hence, SVs may have pro-
found effects on gene regulation. In particular, CNVs drive pathogenesis by changing the num-
ber of copies of genes or CREs [51]. An increasing number of studies indicate that non-coding
CNVs are as important as coding CNVs in driving tumorigenesis or abnormalities [52, 53]. For
instance, non-coding CNVs altering CREs are a major cause of congenital limb malformations
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[54]. In particular, the duplication of a BMP2 enhancer is associated with human limb malfor-
mation [55]. Also, duplications in the zone of polarizing activity regulatory sequence (ZRS)
cause SHH misregulation, which can result in a number of limb abnormalities [56, 57]. In ad-
dition, a duplication involving a distant potential CRE of IHH leads to the IHH misregulation
during digit and skull development [58]. Further, there is evidence showing a robust association
between a CNV located in the promoter of MAPKAPK2 and risk as well as prognosis for lung
cancer, suggesting the potential of this CNV as a biomarker for susceptibility and prognosis
for lung cancer patients [59]. Also CNVs covering a distal PAX5 enhancer can lead to gene
misregulation in chronic lymphocytic leukemia [60]. All these observations suggest that CNVs
can have pathogenic effects by altering CREs, something that has been under-appreciated for
decades.
Moreover, CNVs can also rewrite promoter-enhancer interactions by disrupting TAD struc-
ture, which, in turn, can cause abnormalities and diseases [61, 62]. In particular, the deletion of
a TAD boundary may lead to the fusion of two adjacent TADs, bringing enhancers from neigh-
boring TADs to activate oncogenes (“enhancer hijacking”, [63]). Also, CNVs can facilitate the
formation of new boundaries, splitting one TAD into sub-domains and consequently abrogating
interactions between enhancers and promoters [64]. For example, the disruption of the TAD en-
compassing WNT6, IHH, EPHA4 and PAX3 loci can result in human limb malformations [61].
Fusion of the TAD compassing oncogenes TAL1 and its adjacent TAD leads to activate TAL1
of lymphoblastic leukemia [65]. Similarly, fusion of the TAD compassing oncogenes PDGFRA
and its adjacent TAD cause activation of PDGFRA of gliomas patients [66]. The fragmentation
of a TAD harboring the tumor suppressor gene TP53 leads to misregulation of a number of genes
in prostate cancer cells [64]. Taken together, perturbation of TADs are closely associated with
gene expression misregulation in cancer.
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1.3 Identification and characterization of CREs in the human
genome
Due to their important role in evolution, development, and disease, it is essential to identify
and characterize all CREs in the genome. However, the identification of CREs still remains a
big challenge [67]. First, CREs are scattered across the 98% of the human genome not encoding
protein, resulting in a large search space [68]. Also, as stated above, the locations of CREs
are highly variable relative to their target genes. Thus, enhancers do not necessarily impact
their closest promoters; instead, they can bypass adjacent genes to regulate genes located more
distantly [8, 69]. Furthermore, CREs activity is highly dynamic and tissue-, cell-, time- or
condition-specific [70].
1.3.1 Comparative genomics
Comparative genomics can be used to explore the similarities and differences between the
genomes of two or more species, subspecies or individuals of the same species [71]. Several
studies have examined the evolution of CREs using comparative genomics, revealing that many
CREs are under selective constraint and more evolutionary conserved than non-functional se-
quences [72]. Moreover, many conserved non-coding elements (CNEs) have been shown to act
as CREs. Thus, approximately 500 sequences in the human genome displaying 100% sequence
identity over at least 200 bp with sequences in the mouse and rat genomes have been found to
act as enhancers [73, 74]. Because they are perfectly conserved, these sequences are referred
to “ultra-conserved elements (UCEs)”. Furthermore, approximately 1,400 highly conserved el-
ements (HCEs), displaying at least 70% sequence identity over 100 bp between the human,
pufferfish and fugu genomes exhibited enhancer activity in one or more tissue in functional
assays [75].
The alignment of different genomes is the first step for identifying conserved elements. The
BLAST-Like alignment Tool (BLAT, [76]) is a fast alignment tool that indexes a genome by
recording all non-overlapping k-mers and their positions in the genome. It is often used to
search for sequences in the genome that are closely related to a query sequence. BLAT is op-
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timized to identify DNA sequences of length 25 bp or more and with at least 95% similarity.
To take advantage of the large number of genome sequences, approaches such as a phastCons
[77] rely on multiple alignments while considering the phylogeny of the species that are repre-
sented. Specifically, phastCons uses a phylogenetic hidden Markov model (phylo-HMM) [77].
The phylo-HMM consists of two states: a “conserved” state and a “non-conserved” state. The
phastCons tool uses maximum likelihood to estimate the parameters of the phylo-HMM based
on the genomes of multiple species. The phylo-HMM can be then used to assign a score to each
nucleotide in a genome reflecting the probability that the nucleotide is in a “conserved” state of
the phylo-HMM. In this manner, phastCon can identify “conserved elements” as segments of
the alignment that are likely to have been “generated” by the conserved state of the phylo-HMM.
phastCons has been used to identify CNEs for different sets of species [78].
Because orthologous sequences usually share the same functions, their identification is cen-
tral to comparative genomics. Reciprocal Best Hits (RBH) in the genomes of two species are a
common working definition of orthology. Specifically, RBH are defined as two sequences, each
in a different genome, which are each other’s best hits [79]. For each sequence in a genome,
the sequence in the other genome that shares the best alignment score with it is defined as its
(single-directional) best hit. BLAT is often applied to quickly find sequence hits [80], in partic-
ular between closely related genomes.
Hence, comparative genomics has established itself as a valuable approach to identify can-
didate CREs in the genome [81].
1.3.2 Next-generation sequencing (NGS)
Another approach for identification and characterization of CREs is to apply next-generation
sequencing (NGS) technologies, which have emerged as a turning point in uncovering the gene-
regulatory landscape in the genome. Large international research consortia such as the Encyclo-
pedia of DNA Elements (ENCODE) [82] and Roadmap Epigenomics Mapping [83] have been
established with the purpose of identifying all functional elements in the human genome. They
aim at constructing a comprehensive CRE database through high-throughput data analysis.
NGS technologies can produce multi-dimensional genome-wide data. Thus, mRNA se-
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quencing (mRNA-seq) is widely used to analyse transcriptomes for a wide range of studies.
Specially, mRNA-seq can be used to quantify gene expression levels or identify both known and
novel transcript isoforms or gene fusions [84]. In addition, chromatin immunoprecipitation fol-
lowed by next-generation sequencing (ChIP-seq) is applied to generate maps of TF binding and
histone modifications across the entire genome. The latter mainly comprises the monomethy-
lation of histone H3 at Lys4 (H3K4me1), enriched at enhancers; the trimethylation of H3K4
(H3K4me3) at promoters; the H3K27 acetylation (H3K27ac) at active enhancers and promoters;
the H3K27 trimethylation (H3K27me3) at constitutive heterochromatin regions and the H3K9
trimethylation (H3K9me3) at facultative heterochromatin region [85, 86]. In particlar, different
combinations of enriched histone modifications can annotate different cis-regulatory elements
accurately. H3K4me1 and H3K27ac are enriched at active enhancer; H3K4me3 and H3K27ac
are found at the active promoters; H3K4me1 and H3K27me3 or H3K9me3 are associated with
poised enhancer. Integrating mRNA-seq and ChIP-seq analysis is crucial to decipher the gene
regulatory landscape underlying development, evolution and disease.
Further, NGS technologies can be used for studying chromatin structure and accessibility.
Chromatin accessibility represents the degree to which nuclear proteins such as TFs, are able
to physically contact the DNA [87]. Specifically, accessible genomic regions comprises 2-3%
of total DNA sequence. Yet over 90% accessible genomic regions are captured bound by TFs
[87]. TF binding has been found to be determined by chromatin accessibility as well as sequence
patterns. Therefore, chromatin accessibility has emerged as a powerful marker for detecting ac-
tive CREs. A variety of methods enable us to identify whether the chromatin is open or closed,
active or inactive. The techniques include Deoxyribonuclease I (DNase I)-hypersensitive site
sequencing (DNase-seq), formaldehyde-assisted isolation of regulatory elements (FAIRE-seq),
and assay for transposase-accessible chromatin (ATAC-seq). Finally, chromosome conforma-
tion capture or “Hi-C” protocols, which are also based on high-throughput sequencing technolo-
gies, can be applied to investigate chromatin-chromatin interactions, the 3D spatial organization
of the genome, and the interactions between genes and distal CREs [31].
These technologies have facilitated the description of the genome-wide landscape of gene
expression regulation.
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1.4 Public data for multi-assay genomic investigation of gene
regulation and disease
With the rapid development of NGS technologies, large consortia have generated extensive
multi-assay datasets. The development of bioinformatics approaches to analyze such public data
resources has great potential to benefit biological and medical research.
For example, ENCODE [82] is an ongoing international collaboration that generates and
provides a variety of data and methods to identify CREs in the human genome. Used Techniques
include RNA-seq, ChIP-seq, DNase-seq, DNA-methylation arrays, bisulfite sequencing, and
FAIRE-seq. Notably, ENCODE has systematically mapped TFBSs, candidate CREs, histone
modifications and chromatin structure for numerous human tissues and cell lines.
In addition, large-scale databases have been generated to identify variants in the genomes of
patients with various diseases. Particularly, in the last decades two large international consor-
tia, the Cancer Genome Atlas (TCGA, [88]) and the International Cancer Genome Consortium
(ICGC, [89]), have produced and analyzed large-scale whole-genome sequencing (WGS) data
for a variety of cancer types. They have also developed a variety of computational pipelines
and tools to accurately detect cancer-related variants. These programs have made remarkable
progress in detecting protein-coding variants that act as cancer drivers and in elucidating their
causative effects. Specially, they found a set of protein-coding genes with known causal as-
sociations with multiple cancers. These genes are a hallmark of cancer and were dubbed as
pan-cancer genes [90].
Compared to protein-coding variants, there is less progress in understanding the pathogenic
effects of non-coding variants. The Genome-Wide Association Studies (GWASs) have found
that more than 80% of disease-associated variants fall in non-coding sequences of the genome
[91]. These variants can cause gene expression misregulation via different mechanisms, includ-
ing modifying CREs, non-coding genes with regulatory functions like long non-coding RNAs
(lncRNAs), or disrupting TAD structure [92]. Hence, non-coding variants should draw more
attention and be better studied for uncovering their roles in gene expression misregulation in
disease.
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1.5 Research questions
Medicine comprises three critical components: prognosis, diagnosis and therapy. Identi-
fying relevant genomic variants could permit the personalization of each of these components.
In other words, integrating clinical information and genomic variation is necessary for moving
from one-size-fits-all treatments to personalized precision medicine. Notably, non-coding vari-
ants are likely to have strong clinical implications. For instance, GWAS and sequencing studies
have verified that many non-coding variants are involved in cancer [93]. Moreover, increasing
evidence from clinical studies suggests that non-coding variants can be efficient biomarkers for
drug-induced toxicity and drug response [94]. Many of such non-coding variants are presumably
located in CREs [95, 96].
In general, a gene is rarely regulated by a single CRE; instead, genes are often controlled
by multiple CREs that act cooperatively [97]. Some cooperative CREs may be scattered over
distances of several hundred kb in the genome [98]. Together with their target gene(s), these
CREs form regulatory units [99]. Some of these regulatory units are small and contain a few
CREs. For example, CREs are found to be clustered together in the genome, co-regulating gene
expression [100]. Moreover, “super-enhancer” comprising clusters of enhancer play a key role
in controlling gene expression in cell identity and diseases [101, 102]. Other regulatory units,
such as TADs, are megabase-sized regions encompassing thousands of genes and CREs [28].
Regulatory units can be disrupted, leading to gene expression misregulation. For instance, a
small deletion or mutation can disrupt the interactions between individual enhancer ofWap gene
by 99% [103]. Also, TADs have been found to be highly conserved across different tissues,
cell types and species [104, 31]; because of this, it has been inferred that they are an inherent
feature of chromatin organization in the genome. However, TADs are subject to alteration,
especially in the context of cancer [105]. In particular, TADs boundaries can be disrupted by
SVs, and the perturbation of TADs could drive tumorigenesis by bringing together inappropriate
CREs or disrupting CRE interactions. Elucidating how the disruption of TADs influences cancer
progression could provide new insights for personalized medicine.
New computational methods are needed to gain more knowledge about how regulatory units
are involved in gene expression regulation or misregulation. Some unanswered questions about
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regulatory units include:
i) how to identify regulatory units in the genome;
ii) how to characterize regulatory units;
iii) how CREs in regulatory units regulate gene expression cooperatively;
iv) what can influence or maintain the functions of regulatory units underlying evolution and
development;
v) what can disrupt regulatory units and how does the disruption of regulatory unit impacts
gene expression disease.
This thesis aims at characterizing regulatory units and understanding their roles in gene ex-
pression regulation. Particularly, we explore the causes and consequences of regulatory unit
disruption underlying adaptive evolution, development, and disease. Specifically, this thesis is
separated into two parts:
1. The first part focuses on the identification and characterization of small regulatory units
consisting of two CREs. Using CNEs as proxies for CREs, we investigated which pairs of
CNEs (CNE-CNE pairs) in the human genome are likely to act as regulatory units. Sun at
al [106] reported that the distance between two adjacent CNEs shows conservation in ver-
tebrates. Hence, we hypothesized that the degree of conservation of inter-CNE sequences
of CNE-CNE pairs might reflect the potential functions of CNEs.
To examine this, we clustered CNE-CNE pairs according to the degree of conservation
of their inter-CNE sequences and examined the functions of CNEs through exploring the
patterns of their epigenetic profiles. Further, we examined if transposon activity plays a
roles in changing the conservation of inter-CNE sequences, and further influences func-
tions of the CNEs. This part contributes to identify and characterize regulatory units in
the human genome and the evolutionary mechanisms leading to their loss, which might
be associated with adaptive evolution and human genetic diseases.
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2. The second part is about the identification and charaterization of large regulatory units
(TADs) that are commonly perturbed in cancer. In addition, we examined by which mech-
anism cancer-related CNVs can disrupt TADs. We provide a proof-of-principle to demon-
strate the prognostic value of TADs in patient survival outcomes. This part contributes
to understand the relationship between non-coding variants and TAD disruption in can-
cer, and provides new insights for the development of novel diagnostic, therapeutic and
preventive strategies in cancer.
The identification and characterization of regulatory units is necessary to understand how
changes in gene expression regulation contribute to evolution, development, and disease.
13
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2. Results
The research presented here aimed at investigating the functional potential of the non-coding
sequence with the aid of bioinformatics tools and genomic data generated by international con-
sortia such as ENCODE and TCGA (see Figure 2.1). Specifically, the first part of the chapter
is devoted to the identification and characterization of novel small regulatory units consisting
of pairs of adjacent CNEs and the inter-CNE sequences in between [107]. We found that pairs
of CNEs with mildly contracted or conserved inter-CNE distances often act as regulatory units
consisting of two CREs with similar regulatory activities. This regulatory units can be disrupted
by transposon activity. Interesting, we also found that transposons often give rise to redundant
CREs [108]. The second part of the chapter provides insights into how the disruption of large
regulatory units such as TADs contributes to gene expression misregulation in cancer [109]. In
the context of cancer, we also investigated how knocking-out the mutated KRAS in pancreatic
cancer cell lines with a heterozygous KRAS mutation with the clustered regularly interspaced
short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system affected the
expression of genes involved in cell growth, cell maturation, and cell death [110].
2.1 Small regulatory units in evolution and development
Comparative genomics has identified thousands of CNEs across multiple species that are
of particular interest because of their potential role as CREs [111, 112]. In addition, the length
of the sequences between two CNEs, in particular, HCEs and UCEs, has been shown to exhibit
high conservation across vertebrates [113, 106]. Previous research also reported a correlation be-
tween the transposon density of the inter-CNE sequence and the conservation of its length, with
longer sequences displaying higher transposon densities [113, 106]. Based on these observa-
tions, we hypothesized that the inter-CNE sequences might contain elements that are functional
or structurally relevant which can be perturbed by transposon activities.
To test this, we first developed a new method to quantify degree of conservation of the
distance in between two adjacent CNEs (inter-CNE distance) and analyzed the epigenetic profile
of the CNEs. Then, we investigated if transposon activity influences the conservation of inter-
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Figure 2.1: TADs are represented as red triangle. Boxes in yellow, green, and blue represent gene, CREs, and adjacent pairs of
CREs that are evoluধonary conserved (“funcধonal CNEs”), respecধvely. The alteraধon of large regulatory units, such as TADs, or
small regulatory units, such as pairs of adjacent CREs, could modify regulatory interacধons. For example, the fusion of two ad-
jacent TADs could lead to the formaধon of a interacধons between a gene and a CRE, whereas the change of inter-CNE distance
could lead to the loss of interacধon between two CREs and, in turn, to the loss of regulatory funcধon.
CNE distances and affects the functions of the CNEs [107].
We extracted 21,367 CNEs in the human genome from the PhastCons database [77]. Pairs
of adjacent CNEs without any other conserved element in between were defined as CNE-CNE
pairs. To assess the conservation of the genomic distance between the CNEs of the CNE-CNE
pairs, we searched for the ortholog of each CNE in other 22 vertebrate genomes (see Table 2.1).
Specifically, we used BLAT to identify RBHs for each of the CNEs in the human genome. A total
of 5,657 CNE-CNE pairs were conserved in mammals and defined as mammalian conserved.
Among these CNE-CNE pairs, 1,956 were further conserved in at least two non-mammalian
species and defined as deeply conserved (see figure 2.2A).
Species
Human Turtle
chimp Lizard
Marmoset Frog
Mouse Zebrafish
Dog Fugu
Armadillo Rat
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Species
Elephant Rhesus
Opossum Microbat
Platypus Panda
Chicken Pig
Zebra finch Dolphin
Rhinoceros
Table 2.1: Species used to idenধfy mammalian conserved and deeply conserved CNE-CNE pairs.
We next inferred the inter-CNE distance of CNE-CNE pairs in the common mammalian
ancestor based on the inter-CNE distance of CNE-CNE pairs in the human genome and their or-
thologs in the 16 mammalian species. We introduced the “relative distance difference (nRDD)”
to quantify the relative changes in the distance between adjacent CNEs of CNE-CNE pairs in
the modern mammalian genomes (see Figure 2.2B), calculated as follow:
nRDD =
dh
Gh   drGr
dh
Gh
+ drGr
2
where dh and dr were the distances between the midpoints of two adjacent CNEs in the species
of interest and the common mammalian ancestor, respectively. Gh and Gr were the genome
sizes of the species of interest and the common mammalian ancestor, respectively. Therefore,
dh
Gh and
dr
Gr were the genome size-normalized distances for the species of interest and the common
mammalian ancestor. By computing genome size-normalized distances, wewere able to identify
changes in the inter-CNE distances that were independent from changes in the overall genome
sizes.
The nRDD values can be used to assess changes in the inter-CNE distance. Thus, nRDD
values close to 0 represented no changes in the distances relative to the common mammalian
ancestor; negative and positive nRDD values indicated inter-CNE contraction and expansion in
the species of interest compared to the common mammalian ancestor, respectively.
We further divided the human CNE-CNE pairs into ten equal-sized groups according to
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Figure 2.2: Distances in between adjacent CNEs (inter-CNE distances) were highly conserved across different species. A) We
idenধfied a total 321,621 CNE-CNE pairs in the human genome; 5,657 were conserved in at least human and platypus (“mam-
malian conserved’’, in blue) and 1,956 are further conserved in at least two non-mammalian vertebrates (“deeply conserved’’, in
green). A total of 3,140 CNE-CNE pairs are conserved in at least human and two non-mammalian vertebrates (green and or-
ange). B) Inter-CNE distances for human and mouse CNE-CNE pairs, compared to the common mammalian ancestor. The thick
black lines represented genomes for human, mouse and common mammalian ancestor (reference). The genome sizes are indi-
cated byGh (human),Gm (mouse) and Gr (reference). The two gray squares refer to adjacent CNEs. dh, dm and dr represent
the inter-CNE distance (in bp) for the species we describe above. The genome size-normalized distance for each species is the
inter-CNE distance divided by the genome size. The genome size-normalized distance of species of interest (human, mouse)
is compared to that of the common mammalian ancestor to idenধfy the inter-CNE expansion and contracধon. (Adapted from
[107]).
increasing nRDD values. Compared to the commonmammalian ancestor, groups 1-3 comprised
the CNE-CNE pairs with contracted inter-CNE distances, groups 4-7 referred to the CNE-CNE
pairs with relatively conserved inter-CNE distances, and groups 8-10 contained the CNE-CNE
pairs with expanded inter-CNE distances.
Interestingly, we observed that the density of transposon, including DNA, LTR, LINE and
SINE, gradually increasedwith nRDD value. Nevertheless, all groups except group 10 exhibited
significantly lower transposon densities than expected from the genome, whereas the extremely
expanded group 10 showed no significant difference in transposon densities compared to ex-
pected by chance. These observations suggest that transposon activity might play an active role
in inter-CNE expansion and contraction.
In order to assess if CNE-CNE pairs with different changes of inter-CNE distances are as-
sociated with any regulatory functions, we investigated the epigenetic profiles of the CNEs and
the inter-CNE sequence of each CNE-CNE pair in each of the ten groups. The histone modifi-
cations contained H3K4me1, H3K4me3, H3K27ac, H3K27me3 and H3K9me3 for each of 21
human tissues from ENCODE. For this purpose, we applied an unsupervised clustering method
called Self Organized Map (SOM). Specifically, we clustered the CNE-CNE pairs into 12 self-
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organizing units according to their enrichment profiles for five histone modifications at:
1. the 300bp sequences centered at the left CNE and
2. right CNE of the CNE-CNE pair;
3. the entire inter-CNE sequence of the CNE-CNE pair; and
4. the 200bp region with the highest mean enrichment level within the inter-CNE sequence
for each histone modification.
We next clustered the self-organizing units according to their different epigenetic profiles: i)
no or low cis-regulatory activity; ii) low enrichment level at the CNEs and inter-CNE sequences,
but relatively high enrichment level at the latter; iii) high enrichment levels at both CNEs and
at the inter-CNE sequence, in particular, for H3K27me3; and iv) high enrichment levels for
H3K4me1, H3K4me3 and H3K27ac across the entire sequence (see Table 2.2). While cluster
iii) represented poised enhancers, cluster iv) comprised CNE-CNE pairs in which both CNEs
are most likely act as active enhancers or promoters.
Clusters of units Fraction of CNE-CNE pairs Histone modification enrichment
i 56% -
ii 34% H3K4me1, H3K9me3, H3K27me3
iii 5% H3K27me3
iv 5% H3K4me1, H3K3me3, H3K27ac
Table 2.2: Epigeneধc profiles of clusters of self-organizing units
Depending on the tissue, 19% to 77% of all the CNE-CNE pairs in cluster iv exhibited
higher enrichment levels for H3K27ac in both CNEs compared to random genomic sequences,
suggesting that the CNEs of these pairs act as a small regulatory units.
We further performed an enrichment test to assess if any nRDD groups display enrichment in
clusters of self-organizing units. Interestingly, we observed nRDD group 3 and 4-7 particularly
enriched in the self-organizing units of cluster iii and iv, whereas nRDD group 1-2 and 8-10
enriched in the self-organizing units of cluster i and ii. These findings strengthen the hypothesis
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that different degrees of conservation of the inter-CNE distance are associated with different
epigenetic profiles. In particular, the CNEs in the CNE-CNE pairs with mildly contracted or
conserved inter-CNE sequences are most likely to act as poised and active enhancers, whereas
CNEs of the CNE-CNE pairs with extreme contractions or expansions display no or very low
cis-regulatory activities. We performed analogous analyses for the CNE-CNE pairs in the mouse
genome, with findings similar to human.
In summary, this study identified novel regulatory units consisting of CNE-CNE pairs with
mildly contracted or conserved inter-CNE distances, hinting at inter-CNE distances being rele-
vant to the function of the CNEs. Moreover, the function of these units appears to be disrupted
by transposon activity.
2.2 Disruption of large regulatory units in cancer
The disruption of regulatory units can lead to gene expression misregulation. Large regula-
tory units such as TADs are subject to perturbations in the context of cancer [105]. In particular,
non-coding CNVs can disrupt TAD structure and rewrite enhancer-promoter interactions, lead-
ing to diseases and abnormalities. Therefore, prioritizing non-coding CNVs disrupting TADs
and elucidating how the disruption of TADs influences gene expression in tumorigenesis might
provide new insights for personalized medicine.
We first developed a new algorithm to construct a consensus TAD map representing the
TADs that are prevalent across 24 different normal tissues/cell line. Thus, 1,467 consensus
TADs were identified in the human genome. We further refer to them simply as “TADs”. To
detect the distribution of recurrent CNVs within the TADs, we utilized CNVs data from 10,435
patients of cancer types from TCGA Data Portals. We observed a weak correlation between
the size of the TADs and the number of CNVs that they comprised (Spearman’s correlation
coefficient = 0.32), suggesting that the distribution of CNVs is independent of the size of TADs.
Hence, TADs enriched for CNVs might be involved in cancer mechanisms.
To identify the TADs with unusual CNVs enrichment, we compared the number of patients
with CNVs overlapping with each TAD to the expectation from the human genome according to
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Figure 2.3: The conceptual framework contains key steps of the study.
their sizes, and detected 79 (6%) TADs significantly enriched with CNVs. These TADs were as-
sociated with multiple biological process, cellular components and molecular functions related
to pathogenic mechanisms. In particular, they were associated with type I interferon response,
natural killer cell activation and immune response, which are related to tumor immune surveil-
lance [114]. Interestingly, distinct cancer types showed different subset of TADs enriched with
CNVs, with a median 64 TADs significantly enriched with CNVs. Furthermore, the same 13
TADs were enriched for CNVs in the genomes of the patients of at least 15 different cancer
types. These 13 TADs might be considered a pan-cancer mutational signature, but none showed
any enrichment for pan-cancer genes, suggesting that other pathogenetic mechanisms might be
involved in.
To identify the TADs that are commonly disrupted in cancer and the non-coding CNVs that
contribute to their disruption, we developed a novel framework [109]. Further, we applied
LASSO Cox Regression Model to assess the prognostic power of CNVs in TADs on predicting
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and explaining patient survival outcomes (see Figure 2.3).
To assess the prognostic value of the TADs enriched for CNVs in patient survival outcome,
we trained a LASSO Cox regression model for each of 19 cancer types (see Table 2.3). The
variables or features used to train the models comprised the age and sex of the patients as well
as the presence or absence of CNVs in each of the TADs enriched with CNVs.
Cancer type Project id
LGG Brain Lower Grade Glioma
KIRP Kidney renal papillary cell carcinoma
UCEC Uterine Corpus Endometrial Carcinoma
READ Rectum adenocarcinoma
GBM Glioblastoma multiforme
KIRC Kidney renal clear cell carcinoma
SARC Sarcoma
BRCA Breast invasive carcinoma
OV Ovarian serous cystadenocarcinoma
ESCA Esophageal carcinoma
BLCA Bladder Urothelial Carcinoma
CESE Cervical squamous cell carcinoma and endocervical adenocarcinoma
COAD Colon adenocarcinoma
HNSC Head and Neck squamous cell carcinoma
LUSC Lung squamous cell carcinoma
STAD Stomach adenocarcinoma
LIHC Liver hepatocellular carcinoma
PAAD Pancreatic adenocarcinoma
LUAD Lung adenocarcinoma
Table 2.3: Cancer types used to construct TAD- and gene-based LASSO Cox Regression models.
For nine out of the 19 cancer types, we were able to obtain reliable models, with median
c-index values from 0.55 to 0.8 (see Figure 2.4). For reference, these TAD-based models were
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compared to gene-based models, trained and tested in the same manner. Compared to the gene-
based models, TAD-based models performed better in BRCA, OV, SARC and UCEC, worse
in KIRP, KIRC and GBM; and showed no difference in LGG and READ. In total, the models
identified 35 prognostic TADs. Out of these, 32 were exclusive to one cancer type.
Interestingly, 19 out of 35 prognostic TADs did not comprise any pan-cancer genes, indicat-
ing that the prognostic power of the TADsmight lie in non-coding variants. A remarkable case is
SARC (sarcoma). No good gene markers have been identified so far for SARC [115, 116, 117],
and this is consistent with the poor performance of our gene-based model (see Figure 2.4). In
contrast, the TAD-based model showed a reliable performance. None of the five prognostic
TADs for SARC comprised any pan-cancer genes. In total, 16 out of the 35 prognostic TADs
comprised pan-cancer genes, but the prognostic value of such TADs was not necessarily related
to the presence of pan-cancer genes. These results indicate that the presence of a CNV in a TAD
can be as informative as the presence of a CNV in a pan-cancer gene.
In order to have biological insights into the prognostic features of the TADs, we constructed
a consensus TAD map for the cancer genome. The cancer TAD map comprised 1,622 consen-
sus TADs. By comparing the TAD maps constructed for the normal and cancer genomes, we
separated the TADs in the normal genome into three categories:
1. constitutive: 643 normal TADs showed a high degree of conservation when compared to
their counterparts in the cancer genome;
2. perturbed: 505 normal TADs displayed remarkable differences to cancer TADs; and
3. ambiguous: the remaining 319 normal TADs exhibited intermediate changes or similari-
ties compared to cancer TADs.
A large fraction of the TADs displayed a relatively high degree of conservation, in agreement
with [104, 31]. In addition, there were 505 TADs with substantial perturbations, which might be
related to the presence of CNVs. Hence, we next investigated and compared the distribution of
CNVs in constitutive and perturbed TADs. We hypothesized that CNVs might disrupt the TAD
boundaries. Hence, we extracted two specific subsets of perturbed TADs:
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Figure 2.4: The boxplot shows the c-index (CI) computed on 1,000 random test sets of paধents, for 19 cancer types. TAD- and
gene-based models are shown in yellow and blue, respecধvely. The red dash line represents CI = 0.55 and black dash line for CI
= 0.5. The asterisk in red (“*”) indicates that TAD- and gene-based model is significant different with p-value < 0.05 (Wilcoxon
rank-sum test). C-index = 1 indicates perfect predicধon whereas c-index = 0.5 refer to random predicধon. Nine of the 19 TAD-
based models exhibited a reliable performance (CI > 0.55); out of those nine models, four were significantly beħer than the
corresponding gene-based models, three performed worse, and two were similar.
(i) a subset of 111 TADs that were fused with at least another TAD into a larger TAD in the
cancer genome; and
(ii) a subset of 120 TADs split into two or more TADs in the cancer genome.
Interestingly, both subsets displayed higher densities of CNVs than constitutive TADs. Specif-
ically, (i) showed general a enrichment for CNVs, whereas (ii) displayed a stronger enrichment
of CNVs towards the center of the TAD, at the location of the newly formed TAD boundary.
These findings highlight the association between the presence of CNVs and the disruption
of TAD boundaries, suggesting that CNVs can either lead to the elimination of existing bound-
aries or induce the formation of new boundaries. Moreover, 34% of 35 prognostic TADs were
perturbed, indicating that approximately one third of the prognostic TADs might gain predictive
power directly from the perturbation of the three-dimensional structure.
In summary, we systematically explored a TAD-basedmodel for capturing the effects of non-
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coding variants in cancer mechanisms. We found that CNVs disrupting TADs can be used as as
effective predictive markers for broad types of cancer. This study provides a novel framework
for prioritizing non-coding variants for the development of personalized medicine.
To conclude, this thesis developed new computational frameworks to identify and charac-
terize regulatory units in the human genome, as well as study how their disruption influences
gene expression in human disease.
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3. Discussion
To identify and characterize regulatory units in the human genome, we developed novel
algorithms together with bioinformatics tools, and analyzed large-scale genomic data obtained
from open resources ENCODE and TCGA. Specifically, we concentrated on identifying novel
small regulatory units and investigating disruptions of large regulatory units in the context of
evolution, development, and disease.
Our first study identified and characterized novel regulatory units in the human genome.
There are many studies investigating the roles of non-coding genomic sequences in the human
genome. CNEs have been shown to serve as CREs, and we have shown that the length of the ge-
nomic sequences in between two adjacent CNEs, or inter-CNE sequences, exhibits high conser-
vation across different species, but can be disrupted by transposon activity. These observations
suggest that the inter-CNE sequences contain functional elements or are structurally relevant.
In contrast to identification of the changes of inter-CNE distance in the human genome relative
to the other seven species [113, 106], we integrated a certain number of mammalian species to
infer the inter-CNE distances of the extinct common mammalian ancestor, and used it as refer-
ence to identify human-specific changes in inter-CNE sequences. In the search of the causes of
inter-CNE contractions and expansions, we identified an association between transposon activ-
ities and changes in inter-CNE sequences. Specifically, transposon deletion and insertion are
associated with contraction and expansion of inter-CNE sequences, respectively. We wondered
whether the CNE-CNE pairs and according inter-CNE sequences with varying conservation lev-
els might exhibit any functional patterns; therefore, we applied a SOM-based approach to cluster
CNE-CNE pairs according to the their epigenetic profiles. Interestingly, the CNEs in the CNE-
CNE pairs with conserved or mildly contracted inter-CNE sequences are most likely to be poised
or active enhancers. In addition, the CNEs in a pair always exhibit similar epigenetic profiles,
suggesting that the CNE-CNE pairs with conserved or mildly contracted inter-CNE distance act
as small regulatory units in the genome. An interaction, or epistasis, seems to exist between
the adjacent CNEs, which maintains both CNEs or makes them perform as enhancers. Com-
plex traits or diseases are found to be affected and even determined by epistatic effects [118].
However, the genome-wide detection of epistasis is still challenging [119]. Studies focusing on
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epistasis are essential for elucidating the mechanisms of gene misregulation in the context of
human disease. Our study identified and characterized regulatory units, consisting of pairs of
potentially epistatic CREs. Further examination and validation of their functions is warranted.
Our second study focused on uncovering the effects of disruption of regulatory units in dis-
eases. TADs are highly conserved across species and cell types in the genome, but can be
perturbed, i.e., exhibit structural alterations, in cancer. We hypothesized that the disruption of
TADs might be involved in gene expression misregulation in human disease. To distinguish
perturbed TADs from constitutive or unaltered TADs in cancer, we first developed a novel al-
gorithm to define consensus TADs to represent the cancer and normal genome across multiple
tissues/cell lines. Next, we obtained 79 consensus TADs enriched with CNVs compared to ran-
dom genomic sequences of the same size. The TADs enriched with CNVs did not show any
enrichment of pan-cancer genes, suggesting that other cancer mechanisms might be involved.
After training a LASSO Cox regression model, presence of CNVs in TADs performed as well
as the presence of CNVs in pan-cancer genes in terms of patient survival prediction. Moreover,
the majority of prognostic TADs that display a predictive power are independent of mutated
pan-cancer genes. These observations support that TAD-based model can capture either coding
or non-coding pathogenic variants, thus potentially being an improvement over traditional gene-
based model. Furthermore, TAD-based models may be useful for elucidating the mechanisms
by which non-coding variants might contribute to tumorigenesis. For instance, approximately
34% of 35 prognostic TADs undergo structural variations, suggesting non-coding variants drive
gene expression misregulation by disrupting TADs structure. That is to say, perturbed regulatory
units can be considered as novel prognostic markers. Functional assays are necessary to validate
our findings. Moreover, our study presents a resource for prioritizing non-coding variants for
experimental validation.
The CRISPR/Cas9 system could be used to systematically perturb and characterize candidate
CREs [120, 121], enabling us to gain more insights into gene expression misregulation. In
addition, the CRISPR/Cas9 system could be used for modifying TAD structures and examining
the consequences of TAD disruption.
Taken together, this thesis highlights the importance of regulatory units in gene expression
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regulation. In particular, we identified small regulatory units, consisting of pairs of cooperative
enhancers. Furthermore, our study strengthens the idea that the disruption of regulatory units
can affect gene regulatory interactions, and in turn lead to disease. The list of regulatory units
we identified need follow-up experimental investigation to examine and validate how they are
involved in the regulatory mechanisms underlying development, evolution, and diseases.
27
4 . Conclusion and Outlook
4. Conclusion and Outlook
The 2% protein-coding regions in the human genome have been studied for decades, but the
98% non-coding regions remain less understood. In order to have a comprehensive annotation
of the genome, numerous bioinformatics methods and tools have been developed and applied
to the analysis of large–scale genomic data from open resources, such as TCGA and ENCODE.
Regulatory units, consisting of CREs and/or their target genes, play key roles in gene expression
regulation. This thesis aimed at identifying and characterizing regulatory units and exploring
the causes and consequences of regulatory unit disruption underlying evolution, development,
and human disease.
The first part of this thesis identified and characterized novel regulatory units consisting of
pairs of CNEs (“CNE-CNE pairs”). Specifically, both CNEs in CNE-CNE pairs with conserved
and mildly contracted inter-CNE sequences were found to act as enhancers. Furthermore, the
two CNEs of these pairs act cooperatively, as small regulatory units that could be disrupted by
transposon activity. This study supports the existence of cooperative interactions between adja-
cent CREs, improving our understanding of the mechanism for how selective forces act on CREs
in the context of evolution and human genetic disease. The second part of this thesis investigated
the mechanisms by which regulatory units can be disrupted, leading to gene expression misreg-
ulation in cancer. We provide a proof-of-principle that disrupted TADs can capture pathogenic
non-coding variants involved in cancer mechanisms. In particular, the CNVs disrupting TADs
can be used as effective predictive markers for broad types of cancer, and a substantial fraction
of prognostic features are linked to changes in TADs. This work provides a novel framework
for prioritizing and characterizing cancer-related non-coding variants for the development of
personalized medicine.
Gene expression in humans is complex and controlled by precise temporal and spatial reg-
ulation. In particular, regulatory units comprising multiple interacting CREs act as platforms
to recruit TFs. When the interaction between CREs is disrupted or changed in these regulatory
units, gene expression is subject to change. Thus, the identification and characterization of reg-
ulatory units is essential to understand how changes in gene expression regulation contribute to
evolution, development, and human disease. The interaction between CREs can be additive, re-
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pressive, competitive, synergistic or hierarchical [122]. To explore these interactions, follow-up
experiments, such as functional assays, are necessary. In order to improve the prediction and
characterization of all CREs in the genome, a variety of computational approaches are required.
Our study strengthens the importance of the interactions between the CREs for gene expression
regulation. A systematic dissection and characterization of the interactions between the CREs
might link different interaction types to different evolutionary and disease mechanisms. Thus,
it would be interesting to know whether the conserved inter-CNE distances observed in pairs
of CNEs are also a common feature of larger clustered CNEs. To evaluate how changes in the
distances between the CREs influence the interactions between CREs and their activities, the
CRISPR/Cas9 system could be utilized together with ChIP-seq. Moreover, the integrated anal-
ysis of transcriptomic and epigenomic data would also provide the opportunity to connect the
activity of regulatory units to the expression level of their target gene(s), facilitating the interpre-
tation for how cluster of CREs cooperatively regulate gene expression. Also, multi-dimensional
genome-wide cancer data would enable us to identify changes in gene expression, CRE activity,
and interactions between CREs and their target genes, which would, in turn, help us to uncover
the mechanisms underlying cancer.
Eventually, the combination of computational methods with wet-lab experiments will allow
us to decipher the mechanisms underlying gene expression regulation in the future.
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